Life Expectancy and Rate of Decline After Lung Volume Reduction Surgery

Area of Science:

• Pulmonology
• Thoracic Surgery
• Critical Care Medicine

Background:

• Lung volume reduction surgery (LVRS) guidelines are informed by the National Emphysema Treatment Trial.
• Patients with non-upper lobe emphysema and low exercise capacity are generally poor candidates for LVRS.
• LVRS aims to improve outcomes in severe emphysema patients.

Purpose of the Study:

• To evaluate the long-term outcomes and survival rates of LVRS in selected emphysema patients.
• To assess LVRS as an alternative for end-stage emphysema patients not eligible for lung transplantation.

Main Methods:

• Analysis of patient selection criteria based on the National Emphysema Treatment Trial.
• Review of functional outcomes and survival data for LVRS patients.
• Assessment of emphysema distribution (heterogeneous vs. homogeneous) and baseline exercise capacity.

Main Results:

• LVRS demonstrates durable long-term outcomes up to 5 years in well-selected patients with heterogeneous emphysema.
• Five-year survival rates for LVRS patients range from 63% to 78%.
• Patients with non-upper lobe emphysema and low exercise capacity show poorer outcomes.

Conclusions:

• LVRS is a durable alternative for end-stage heterogeneous emphysema in patients unsuitable for lung transplantation.
• Further research is needed to identify eligible patients with homogeneous emphysema for LVRS.